These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 31694668

  • 1. Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits.
    Zebialowicz Ahlström J, Massaro F, Mikolka P, Feinstein R, Perchiazzi G, Basabe-Burgos O, Curstedt T, Larsson A, Johansson J, Rising A.
    Respir Res; 2019 Nov 06; 20(1):245. PubMed ID: 31694668
    [Abstract] [Full Text] [Related]

  • 2. Impact of synthetic surfactant CHF5633 with SP-B and SP-C analogues on lung function and inflammation in rabbit model of acute respiratory distress syndrome.
    Mikolka P, Curstedt T, Feinstein R, Larsson A, Grendar M, Rising A, Johansson J.
    Physiol Rep; 2021 Jan 06; 9(1):e14700. PubMed ID: 33403805
    [Abstract] [Full Text] [Related]

  • 3. The Synthetic Surfactant CHF5633 Restores Lung Function and Lung Architecture in Severe Acute Respiratory Distress Syndrome in Adult Rabbits.
    Mikolka P, Kosutova P, Kolomaznik M, Nemcova N, Hanusrichterova J, Curstedt T, Johansson J, Calkovska A.
    Lung; 2024 Jun 06; 202(3):299-315. PubMed ID: 38684519
    [Abstract] [Full Text] [Related]

  • 4. A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant.
    Häfner D, Germann PG.
    J Pharmacol Toxicol Methods; 1999 Jun 06; 41(2-3):97-106. PubMed ID: 10598681
    [Abstract] [Full Text] [Related]

  • 5. Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDS.
    Wolfson MR, Wu J, Hubert TL, Gregory TJ, Mazela J, Shaffer TH.
    Pediatr Res; 2012 Oct 06; 72(4):375-83. PubMed ID: 22821059
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
    Häfner D, Ibrahim M, Wollin L, Germann PG.
    Exp Toxicol Pathol; 2003 Jul 06; 55(1):59-68. PubMed ID: 12940630
    [Abstract] [Full Text] [Related]

  • 10. In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits.
    Guo X, Luo S, Amidani D, Rivetti C, Pieraccini G, Pioselli B, Catinella S, Murgia X, Salomone F, Xu Y, Dong Y, Sun B.
    PLoS One; 2020 Jul 06; 15(3):e0230229. PubMed ID: 32168331
    [Abstract] [Full Text] [Related]

  • 11. Intratracheally applied rSP-C surfactant exhibits no anaphylactic shock reactions in a guinea pig model of acute lung hypersensitivity.
    Germann PG, Kemkowski J, Hauschke D, Steinhilber W, Häfner D.
    Exp Toxicol Pathol; 1999 Nov 06; 51(6):495-505. PubMed ID: 10661808
    [Abstract] [Full Text] [Related]

  • 12. Budesonide with surfactant decreases systemic responses in mechanically ventilated preterm lambs exposed to fetal intra-amniotic lipopolysaccharide.
    Hillman NH, Kemp MW, Fee E, Rittenschober-Böhm J, Royse E, Abugisisa L, Salomone F, Musk GC, Jobe AH.
    Pediatr Res; 2021 Aug 06; 90(2):328-334. PubMed ID: 33177678
    [Abstract] [Full Text] [Related]

  • 13. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome.
    Häfner D, Germann PG, Hauschke D.
    Br J Pharmacol; 1998 Jul 06; 124(6):1083-90. PubMed ID: 9720777
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Different effects of surfactant proteins B and C - implications for development of synthetic surfactants.
    Curstedt T, Johansson J.
    Neonatology; 2010 Jun 06; 97(4):367-72. PubMed ID: 20551705
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
    Häfner D, Beume R, Kilian U, Krasznai G, Lachmann B.
    Br J Pharmacol; 1995 Jun 06; 115(3):451-8. PubMed ID: 7582456
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phospholipid Composition in Synthetic Surfactants Is Important for Tidal Volumes and Alveolar Stability in Surfactant-Treated Preterm Newborn Rabbits.
    Calkovska A, Linderholm B, Haegerstrand-Björkman M, Pioselli B, Pelizzi N, Johansson J, Curstedt T.
    Neonatology; 2016 Jun 06; 109(3):177-85. PubMed ID: 26757268
    [Abstract] [Full Text] [Related]

  • 20. Novel therapeutic roles for surfactant-inositols and -phosphatidylglycerols in a neonatal piglet ARDS model: a translational study.
    Spengler D, Winoto-Morbach S, Kupsch S, Vock C, Blöchle K, Frank S, Rintz N, Diekötter M, Janga H, Weckmann M, Fuchs S, Schromm AB, Fehrenbach H, Schütze S, Krause MF.
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan 01; 314(1):L32-L53. PubMed ID: 28860142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.